Drug intelligence / Profile preview

shenshuaining

Development stage
Unknown
Lead developer
Yunnan Ideal Pharmaceutical
Administration
Oral
01

Overview

Shenshuaining is a traditional Chinese medicine (TCM) formulation used primarily for the treatment of chronic kidney disease (CKD) and chronic renal insufficiency. It is available in capsule and tablet forms. The formula contains multiple herbal ingredients including Taizishen (Pseudostellaria heterophylla), Coptis (Coptis chinensis), French Pinellia (Pinellia ternata), Tangerine Peel (Citrus reticulata), Poria (Poria cocos), Rhubarb (Rheum palmatum), Salvia miltiorrhiza, Achyranthes bidentata, Safflower (Carthamus tinctorius), and Licorice root. Mechanistically, Shenshuaining is believed to promote blood circulation and remove blood stasis, invigorate qi and spleen function according to TCM theory[5][6]. Pharmacological studies suggest it may increase renal blood flow, promote excretion of toxins such as indoxyl sulfate in uremic patients on dialysis[3], inhibit compensatory hypertrophy of the kidney remnant tissue after injury or nephrectomy[2], regulate metabolic state in CKD patients[2], reduce serum creatinine and BUN levels while increasing hemoglobin levels[2]. Some components like Tanshinone IIA from Salvia miltiorrhiza have demonstrated antioxidant effects and renoprotective properties. It is widely used in China for CKD management to improve symptoms such as low back pain, fatigue, pale complexion, nausea/vomiting/loss of appetite associated with chronic renal insufficiency[1][4][5].

Brand names
ShenshuainingShen Shuai NingShen Shuai Ning CapsuleShenshuaining Jiaonang
Other names
Shen-Shuai-NingSSNShenshuaining pian
02

Targets

TGFB1 (Transforming growth factor Beta-1 proprotein)GPX4 (Glutathione peroxidase 4)SMAD2 (Mothers against decapentaplegic homolog 2)HIF1A (Hypoxia-inducible factor 1-alpha)SMAD7 (Mothers against decapentaplegic homolog 7)

Beyond the preview

Go deeper on shenshuaining.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on shenshuaining.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call